This inventor holds 1 USPTO granted patent. Top assignee: Alkahest, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bartosz Sikorski: Patent Work in Retina-Associated Disease Treatment.
Introduction
Bartosz Sikorski is an inventor associated with Bydgoszcz, Poland, and Alkahest, Inc. His listed patent concerns approaches to treating retina-associated diseases, including wet age-related macular degeneration.
Latest Patents
Sikorski is associated with 1 patent, titled “Methods of Improving Retina-Associated Disease Outcome Using CCR3-Inhibitors.” The disclosure describes administering a CCR3 inhibitory agent before an anti-VEGF agent, with the aim of reducing how frequently the anti-VEGF treatment must be given. It also describes treating a patient with a retina-associated disease who previously received a CCR3 inhibitory agent, using anti-VEGF doses at intervals less frequent than the recommended schedule.
Career Highlights
Sikorski’s listed patent work focuses on combining CCR3 inhibition with anti-VEGF treatment. The proposed approach addresses treatment frequency for wet age-related macular degeneration and other retina-associated diseases.
Collaborations
Sikorski is associated with Alkahest, Inc. His listed coworkers include Jessica A. Powell and Esther Rawner.
Conclusion
Bartosz Sikorski’s patent work explores whether CCR3 inhibitors can support less frequent anti-VEGF administration for patients with retina-associated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
